GREGG TERRANCE H 4
4 · DEXCOM INC · Filed Feb 20, 2018
Insider Transaction Report
Form 4
DEXCOM INCDXCM
GREGG TERRANCE H
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2018-02-15$55.91/sh−10,000$559,095→ 20,882 total(indirect: By Trust)
Holdings
- 11,461(indirect: By IRA)
Common Stock
- 484,559
Common Stock
Footnotes (3)
- [F1]On December 5, 2017, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $55.64 and $56.25. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.